Insider Transactions Reported | CARGO Therapeutics(CRGX)saw insider trading activity on 5/16/2025

CARGO Therapeutics(CRGX) saw insider trading activity on 5/16/2025, there was 1 insider trade during the day.

【History Insider Transaction】

Declare date	Position	Name	Buy/Sell	Quantity	Price per share/USD	Total Amount/USD
5/16/2025	See Remarks	Radhakrishnan Anup	Sell	27404	3.84	105.27k
4/8/2025	Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer	Radhakrishnan Anup	Sell	1629	4.00	6.52k
9/20/2024	President & CEO	Chapman Gina	Sell	2975	25.03	74.46k
9/20/2024	President & CEO	Chapman Gina	Buy	10141	5.03	51.01k
9/20/2024	President & CEO	Chapman Gina	Sell	7166	25.09	179.77k
9/20/2024	Chief Financial Officer	Radhakrishnan Anup	Buy	1600	5.03	8.05k
9/20/2024	Chief Financial Officer	Radhakrishnan Anup	Sell	1600	25.28	40.45k
6/3/2024	--	Samsara BioCapital GP, LLC	Buy	294000	17.00	4998.0k
11/16/2023	--	Samsara BioCapital GP, LLC	Buy	666666	15.00	9999.99k
11/14/2023	--	Third Rock Ventures V, L.P.	Buy	1333333	15.00	20000.0k

[Company Profile]
CARGO Therapeutics, Inc. was incorporated in the state of Delaware in December 2019 as Syncopation Life Sciences, Inc. and changed its name to Cargo Therapeutics, Inc. in September 2022. The company is a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients. The company programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved chimeric antigen receptor T-cell therapies.